SLXN Silexion Therapeutics
- 0.267
- +0.003+1.25%
Silexion Therapeutics News
Silexion Therapeutics Analyst Ratings
Express News | Silexion Therapeutics Corp : Maxim Group Initiates Coverage With Buy Rating; Target Price $1
Silexion Therapeutics to Offer Stock and Warrants
Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit
Express News | Silexion Therapeutics Corp Says in Addition, Resale of up to 15,352,181 Ordinary Shares by the Selling Securityholders
Express News | Silexion Therapeutics Corp - to Issue 5,940,000 Ordinary Shares
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Express News | Silexion Therapeutics : : Preclinical Studies Show Improvements in Stability, Efficacy, Kras Targeting Range for Next-Gen Sirna Candidate Sil-204
Silexion Therapeutics Reports Breakthroughs From SIL-204 Preclinical Studies
Sector Update: Health Care Stocks Decline Tuesday Afternoon
Silexion Therapeutics Stock Trades Higher, Trial Data For Pancreatic Cancer Patients Shows Promise
Market-Moving News for September 24th
Express News | Silexion Therapeutics Corp - Progressing With Development of Next-Gen Product Sil-204
Silexion Therapeutics Announces Significant New Data From Phase 2 Trial of LODER in Non-Resectable Pancreatic Cancer
Express News | Silexion Therapeutics Corp: Announces Significant New Data From Phase 2 Trial of Loder™ in Non-Resectable Pancreatic Cancer
Top Premarket Gainers
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers
Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference
News On Moringa Acquisition Corp. (MACA) Now Under SLXN
Analysis
Price Target
No Data
No Data